Dr Silke Middendorf has experience driving commercial strategy at globally operating businesses
Biomega Group, a European biosciences company, has announced the appointment of Dr Silke Middendorf to the role of CCO.
Middendorf will be responsible for leading the marketing and sales strategies of the business, guiding growth projects to completion while reporting to the company’s CEO.
Middendorf has experience driving commercial strategy at globally operating businesses. Her skills and competencies are a perfect fit for Biomega, the company says, as the business continues expanding in the global nutrition and pet care industries.
Stig Petersen, CEO at Biomega, said: “We are excited to welcome Dr Middendorf to our team and look forward to all the positive contributions she will no doubt make to our business. Silke’s track record speaks for itself, driving sales and marketing development at health and nutrition giants such as Pfizer and Symrise.
“We are very much a culture-driven business, and Dr Middendorf – and her desire to make a real difference – is an ideal fit for our team in terms of our culture, values and mission. We look forward to seeing Dr Middendorf make her mark on the long-term commercial journey of Biomega.”
Dr Middendorf added: “I am extremely pleased to join the talented Biomega team as the company’s new Chief Commercial Officer. The Biomega business has a strong focus on connecting life sciences and nutritional ingredients with sustainability and is offering something fresh and unique to the market. I look forward to playing my part in the international growth of the business and helping to raise the business to even greater heights.”